Hi all,Given the record breaking amount of money being invested in synthetic biology companies, it seemed that 2016 was going to be hard for the industry to top. However, we just crunched the numbers for 2017 and thanks to several late mega-raises from both public and private companies, more than $1.7 billion was raised. See the charts below and check out the story here.

Flagship Pioneering closed a new $618M life science fund, GenScript announced that it has acquired CustomArray to expand its synthetic biology portfolio. GenScript also saw a sharp increase in its stock price after it announced a CAR-T Cell immunotherapy collaboration with Janssen. Thermo Fisher and Juno Therapeutics also announced a new CAR T Partnership. French company DEINOVE launched the production of its first carotenoid molecule.

From our blog, check out Leah Cannon’s article about why diversity matters in founding teams.FREDsense Technologies recently closed a seed round. The Canadian company that spun out from an iGEM project is developing bacterial biosensors to detect chemicals in wastewater:

More exciting news from the field of cultured meat: SuperMeat, an Israeli biotech and food-tech startup, has raised $3M in seed funding to bring clean chicken products to market within three years.

Not bad for January 3rd!Happy 2018!

Regards,

John

Who's Hiring?

Product Scientist: Opentrons, New YorkScientist, Synthetic Biology / Protein Engineering: Arzeda, Seattle, WABioBuilder Teaching AssistantsSenior Scientist, Enzyme Engineering: Amyris, Emeryville, CaliforniaSenior Scientist, Strain Engineering: Amyris, Emeryville, CaliforniaScientist, Cytochrome P450 Engineering: Amyris, Emeryville, CaliforniaScientist, Strain Performance Optimization, PD&E: Amyris, Emeryville, CaliforniaSenior Director, Separations Process Development: Amyris, Emeryville, CaliforniaFeature your job here, click here to contact us

News

Weizmann Institute Event in Israel: Synthetic Biology Applications for a Livable FutureAgricultural Bioscience Company Yield10 Bioscience Announces Closing of $14.5 Million Public OfferingIn The Lab Of The Future, Robots Run Experiments While Scientists Sleep (Forbes)Scientists Are Designing Artisanal Proteins for Your Body (The New York Times)Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William BaumInnovation Drives Operational Challenges that Impact R&D Productivity (Science Exchange)

Copyright © %%current_year_YYYY%%, All rights reserved.SynBioBeta1547 Palos Verdes Mall, #411Walnut Creek, CA 94597About Us | Update Preferences | Unsubscribe | View email in your browser